rs141514155

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The ENST00000472694.1(HBA1):​n.611C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 1,603,218 control chromosomes in the GnomAD database, including 242 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.012 ( 17 hom., cov: 32)
Exomes 𝑓: 0.013 ( 225 hom. )

Consequence

HBA1
ENST00000472694.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0720

Publications

2 publications found
Variant links:
Genes affected
HBA1 (HGNC:4823): (hemoglobin subunit alpha 1) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA1 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Heinz body anemia
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0117 (1789/152288) while in subpopulation SAS AF = 0.0178 (86/4826). AF 95% confidence interval is 0.0148. There are 17 homozygotes in GnomAd4. There are 933 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR,AD,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBA1NM_000558.5 linkc.*46C>A 3_prime_UTR_variant Exon 3 of 3 ENST00000320868.9 NP_000549.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBA1ENST00000320868.9 linkc.*46C>A 3_prime_UTR_variant Exon 3 of 3 1 NM_000558.5 ENSP00000322421.5 P69905

Frequencies

GnomAD3 genomes
AF:
0.0118
AC:
1788
AN:
152168
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00215
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00622
Gnomad ASJ
AF:
0.0424
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0176
Gnomad FIN
AF:
0.0343
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0143
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0148
AC:
3410
AN:
230802
AF XY:
0.0152
show subpopulations
Gnomad AFR exome
AF:
0.00183
Gnomad AMR exome
AF:
0.00516
Gnomad ASJ exome
AF:
0.0373
Gnomad EAS exome
AF:
0.0000582
Gnomad FIN exome
AF:
0.0357
Gnomad NFE exome
AF:
0.0144
Gnomad OTH exome
AF:
0.0196
GnomAD4 exome
AF:
0.0135
AC:
19522
AN:
1450930
Hom.:
225
Cov.:
31
AF XY:
0.0140
AC XY:
10076
AN XY:
720950
show subpopulations
African (AFR)
AF:
0.00195
AC:
65
AN:
33286
American (AMR)
AF:
0.00569
AC:
247
AN:
43420
Ashkenazi Jewish (ASJ)
AF:
0.0394
AC:
1020
AN:
25882
East Asian (EAS)
AF:
0.0000509
AC:
2
AN:
39282
South Asian (SAS)
AF:
0.0204
AC:
1732
AN:
84876
European-Finnish (FIN)
AF:
0.0345
AC:
1788
AN:
51854
Middle Eastern (MID)
AF:
0.0264
AC:
152
AN:
5758
European-Non Finnish (NFE)
AF:
0.0123
AC:
13629
AN:
1106588
Other (OTH)
AF:
0.0148
AC:
887
AN:
59984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1164
2328
3493
4657
5821
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0117
AC:
1789
AN:
152288
Hom.:
17
Cov.:
32
AF XY:
0.0125
AC XY:
933
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00214
AC:
89
AN:
41580
American (AMR)
AF:
0.00622
AC:
95
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0424
AC:
147
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0178
AC:
86
AN:
4826
European-Finnish (FIN)
AF:
0.0343
AC:
364
AN:
10622
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0143
AC:
973
AN:
68018
Other (OTH)
AF:
0.0128
AC:
27
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
91
182
272
363
454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0132
Hom.:
6
Bravo
AF:
0.00852
Asia WGS
AF:
0.00811
AC:
28
AN:
3468

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 31, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 14, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

alpha Thalassemia Benign:2
Aug 09, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 25, 2019
The ITHANET community portal, The Cyprus Institute of Neurology and Genetics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.9
DANN
Benign
0.64
PhyloP100
-0.072
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141514155; hg19: chr16-227456; API